Related content

Developments in antiplatelet therapy for acute coronary syndromes and considerations for long-term management

By Cowley Michael J.   Kuritzky Louis  

Current Medical Research and Opinion, Vol. 25, Iss. 6, 2009-06 ,pp. : 1477-1490

Informa Healthcare

Access to resources Recommend Favorite

Response to Dual Antiplatelet Therapy Does Not Impact Bleeding Risks in Patients Undergoing Oral Surgery after Acute Coronary Syndromes

By  

Cardiology, Vol. 132, Iss. 2, 2015-07 ,pp. : 119-123

Karger

Access to resources Recommend Favorite

Triple versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Adding Cilostazol to Aspirin and Clopidogrel?

By  

Cardiology, Vol. 126, Iss. 4, 2013-10 ,pp. : 233-243

Karger

Access to resources Recommend Favorite

Pre‐treatment with dual antiplatelet therapy in patients with non‐ST‐segment elevation acute coronary syndromes undergoing percutaneous coronary intervention

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 10, 2015-10 ,pp. : 1032-1037

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor

By De Servi Stefano   Navarese Eliano Pio   D’Urbano Maurizio   Savonitto Stefano  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2117-2122

Informa Healthcare

Access to resources Recommend Favorite